Benign Prostatic Hyperplasia. BPH  Benign increase in size of prostate  Hyperplasia of stromal and epithelial cells  Nodules.

Slides:



Advertisements
Similar presentations
Oral Boards Advocate Christ Medical Center. Case 1 CC: HR: BP: RR:
Advertisements

Advances in the Management of BPH
BPH Diagnosis and Medical Treatment
Case 1: George Case 1: George
Supervised by: Dr- Al Traifi. Why LUTS? What are the symptoms? Common causes? Patient work up Details of the Common etiology BPH.
MODULE 5 1/33 Case 5: Sam. MODULE 5 Case 5: Sam 2/33 Patient History  Sam is a 66 year old retired painter & construction worker.  He is distressed.
MODULE 5 1/36 Case 4: Andy. MODULE 5 Case 4: Andy 2/36 History  You have known Andy as a patient for 15 years  Andy is 65 years of age and a retired.
MODULE 5 1/40 Case 3: Chuck. MODULE 5 Case 3: Chuck 2/40 Patient History  Chuck is a 66 year old retired chemical compounder  He is distressed by the.
Chairman Rounds Medicine I Jesse Lester, Kannan Samy, Matt Skomorowski, Dan Verrill.
CBL Review Hope and Jess.
MODULE 5 1/26 Case 6: Anthony. MODULE 5 Case 6: Anthony 2/26 Patient History  Anthony is a 55-year old lawyer.  He has been suffering from voiding complaints.
MODULE 5 1/23 Case 9: Pierre. MODULE 5 Case 9: Pierre 2/23 Patient History  Pierre is 65 years of age who has suffered with benign prostatic hyperplasia.
Anemia Lab MHD I November 3, Case 1 A CBC is ordered on a 32-year old healthy man as part of a life-insurance policy evaluation.
CASE 47: BIPOLAR DISORDER By Ryan Raroque. Bipolar Disorder Spectrum.
Case Study 18: Cirrhosis Skylar Strobel.
Lower urinary tract symptoms (LUTS) in elderly males
 Usually done on the mid stream urine  Fresh voided urine  The container is clean and sterile (for culture )  The sample must be tested within 1hr.
All About the Prostate For Intelligent Internists
MODULE 5 1/46 Case 2: Troy. MODULE 5 Case 2: Troy 2/46 Patient History  Troy is a 59 year old retired school teacher who comes to you for his annual.
Lower Urinary Tract Symptoms (LUTS) in men Kamal Patel GPST2.
2008. Causes of symptoms  Hyperplasia of epithelial and stromal components of prostate  Progressive obstruction of urinary outflow  Increased activity.
Department of Medicine Grand Rounds Clinical Vignette Ilana Bragin January 14 th, 2009 NYU Langone Medical Center Internal Medicine Residency Program.
Medical Therapy of Prostate Symptoms (MTOPS) Jeannette Y. Lee, Ph.D. University of Alabama at Birmingham.
History 2: 70 year old female
Enzyme Case Studies: 1 A 67 year old male two days after sustaining multiple injuries in a motor vehicle accident complains of chest pain. There is no.
Acute Renal Failure Cases. Case 1- HPI 71 yo mw/ fever and dysuria for 2 days Decreased UOP but increased frequency Yesterday vomited 3-4 times and developed.
Scenario 4.3 Mesenteric Ischemia. ECG Chest X-ray.
OSCE Raika Jamali M.D. Gastroenterologist and hepatologist Sina hospital Tehran University of Medical Sciences.
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Benign Prostatic Hyperplasia
OSCE Raika Jamali M.D. Gastroenterologist and hepatologist Sina hospital Tehran University of Medical Sciences.
Urology Update Sanofi- Aventis
NYU Medical Grand Rounds Clinical Vignette Maryann Kwa, MD PGY-3 March 20, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Case 350: A 20-year-old man with an enlarged cervical lymph nodes
Scenario 10.1 Digoxin Overdose. ECG CT Head Radiology Preliminary Read: Normal.
1 Scenario 10.3 Sympathomimetic Overdose. 2 ECG 3 CT Head Radiology Preliminary Read: Normal.
Scenario 10.2 Opioid Overdose. ECG CT Head Radiology Preliminary Read: Normal.
Case Report 1.
Figure 1. Gross specimen of prostate gland.. Figure 2. Microscopic effects of BPH.
Scenario 6.1 Diabetic Ketoacidosis. Chest X-ray ECG.
Scenario 6.3 Thyroid Storm.
Academic day 13/02/2014 MUBARAK ALKABEER HOSPITAL.
Thyroid Case Studies: 1 A 56 year old woman in a pre-comatose state with a temperature of 34C and an enlarged thyroid gland. Hb g/dL, MCV- 105 fL.
Red Blood Cell Indices. Red blood cell indices :are measurement that describe the size and oxygen carrying protein (HB) content of red blood cells. The.
1 Scenario 13.1 Major Burn. 2 Chest X-ray 3 Post-intubation Chest X-ray Preliminary Read: Endotracheal tube in good position. No pneumothorax or infiltrates.
Benign prostatic hyperplasia
ANCILLARY PROCEDURES. Done in the patient CBC Na, K Creatinine SGOT, SGPT 12-L ECG.
Genitourinary Blueprint
Pathology of the Urogenital Tract Male Genital Tract March 24, 2014.
Intestinal Perforation
Table 1. Clinical characteristics of subjects Mean ± s.d. n1363 Age (years)55.6 ± 14.1 Genders, % Males49.1 Females50.9 Diabetes, %44.9 Hypertension, %14.0.
DR. MOHAMMED ALTURKI COSULTANT UROLOGIST. Evaluation of the Urologic Patient The urologist has the ability to make the initial evaluation and diagnosis.
우연히 발견된 폐결절환자 증례 호흡기내과 R1 최윤영/ Prof. 박명재
Benign Prostate Hypertrophy (BPH). Introduction Benign prostatic hyperplasia refers to nonmalignant growth of prostate. – age-related phenomenon in nearly.
BENIGN PROSTATIC HYPERPLASIA Brian Kim, PGY3. A Case…  Mr. X is a 58y/o AAM presents to your clinic complaining of hesitancy, frequency, and nocturia.
Department of oncology. C/C Poor oral intake, abdominal distension (onset: 2 weeks ago) P/H DM (+): detection, medication 중 HTN/Hepatitis/Tuberculosis.
Why Don’t We Do It In Our Sleeve?
GYNAECOLOGY SCREENING 1
هوالشافی دکتر مریم دهقان 91/8/6.
Comorbidity NASH/HCV and HCC
בקרת יצירת תאי דם אדומים
H.Salimi M.D. Department of Urology Hasheminejad Kidney Center.
Supplementary Figure S7
Evaluation and Medical Management of Benign Prostatic Hyperplasia
Scenario 8.1 Eclampsia.
When to Treat the Prostate, the Bladder, or Both?
Clinical Pathology Conference 病史篇
Pycno Pycnogenol® benign prostatic hyperplasia
REVIEW ANATOMY and PHYSIOLOGY
Presentation transcript:

Benign Prostatic Hyperplasia

BPH  Benign increase in size of prostate  Hyperplasia of stromal and epithelial cells  Nodules

Patient W.M.  76 yo  Recurrent UTIs  Acute pyelonephritis  Urinary frequency, urgency, incontinence, and nocturia

Past Medical History  Hypothyroidism  COPD  Obesity  1 ppd smoker  Father – alcoholic  Mother – DM type 2

Review of Symptoms  Strain to initiate urination  Urinary flow stops and then starts  Post-void dribbling

Medications  Ipratropium bromide  Ibuprofen  Levothyroxine  Ferrous sulfate

Case Question 1: For what condition is the patient probably taking ipratroprium bromide?

 Ipratropium bromide is used to relieve bronchial spasms  Anticholinergic

Answer : COPD

Case Question 2: For what condition is the patient probably taking levothyroxine?

 Synthetic thyroid hormone

Answer: Hypothyroidsim

IPSS  International Prostate Symptom Score  8 question survey  Standardize patients

Case Question 3: Based on the patient’s IPSS, is his condition of prostatic enlargement considered mild, moderate or severe?

Case Question 4: Based on the patient’s BMI, is the patient technically overweight or obese?

BMI  Measure of body fat  Underweight < 18.5  Normal weight =  Overweight =  Obesity > 30

Vital Signs  Patient’s BMI = 33.8% BP 135/85 (R arm) 130/85 (L arm) RR 16, unlaboredHT 6’0” P 80 and regularT 98.6 FWT 249 lbs

Physical Exam  All normal  Urinary Function Tests  Uroflowmetry  Transabdominal ultrasound  Pressure flow study

Case Question 5: Which urinary function test(s) is/are consistent with an enlarged prostate?

 Uroflowmetry  Normal: 10 – 21 mL/sec  Patient: 7 mL/sec  Residual Urine Volume  > 50 mL significant  Patient: 110 mL  Bladder Voiding Pressure  Weak < 100 cm H 2 O  Patient: 74 cm H 2 O

Case Question 6: Identify all abnormal results of this patient’s urinalysis

Color StrawBilirubin (-)WBC 2/HPF Appearance ClearKetones (-)RBC 2/HPF SG 1.017Blood (-)Bacteria Trace pH 6.4Urobilinogen (-)Crystals (-) Glucose (-)Nitrites (-)Culture Not indicated

Blood Test Results Na 141 meq/L MCHC 31.8 g/dLLDH 219 IU/L K 3.9 meq/L Plt /mm 3 Bilirubin 1.2mg/dL Cl 109 meq/LWBC 8700/mm 3 Protein 5.9mg/dL HCO 3 32 meq/L Neutros 65% Cholesterol 255mg/dL BUN 15 mg/dL Lymphs 27%Ca 8.7mg/dL Cr.8 mg/dL Monos 5%Mg 2.2mg/dL Glu 119 mg/dL Eos 2%PO 4 2.8mg/dL Hb 13.9 g/dL Basos 1%Uric acid 6.3mg/dL Hct 41%AST 31 IU/LT 4 3.5µg/dL MCV 97 fLALT 41 IU/LTSH 107.9µU/mL MCH 28.7 pg Alk phos 52 IU/LPSA* 5.2ng/mL *PSA 13 months ago was 5.0 ng/mL

Case Question 7: Is the patient experiencing an electrolyte imbalance?

Na 141 meq/L MCHC 31.8 g/dLLDH 219 IU/L K 3.9 meq/L Plt /mm 3 Bilirubin 1.2mg/dL Cl 109 meq/LWBC 8700/mm 3 Protein 5.9mg/dL HCO 3 32 meq/L Neutros 65% Cholesterol 255mg/dL BUN 15 mg/dL Lymphs 27%Ca 8.7mg/dL Cr.8 mg/dL Monos 5%Mg 2.2mg/dL Glu 119 mg/dL Eos 2%PO 4 2.8mg/dL Hb 13.9 g/dL Basos 1%Uric acid 6.3mg/dL Hct 41%AST 31 IU/LT 4 3.5µg/dL MCV 97 fLALT 41 IU/LTSH 107.9µU/mL MCH 28.7 pg Alk phos 52 IU/LPSA* 5.2ng/mL *PSA 13 months ago was 5.0 ng/mL

8. Renal Function? Na 141 meq/L MCHC 31.8 g/dLLDH 219 IU/L K 3.9 meq/L Plt /mm 3 Bilirubin 1.2mg/dL Cl 109 meq/LWBC 8700/mm 3 Protein 5.9mg/dL HCO 3 32 meq/L Neutros 65% Cholesterol 255mg/dL BUN 15 mg/dL Lymphs 27%Ca 8.7mg/dL Cr.8 mg/dL Monos 5%Mg 2.2mg/dL Glu 119 mg/dL Eos 2%PO 4 2.8mg/dL Hb 13.9 g/dL Basos 1%Uric acid 6.3mg/dL Hct 41%AST 31 IU/LT 4 3.5µg/dL MCV 97 fLALT 41 IU/LTSH 107.9µU/mL MCH 28.7 pg Alk phos 52 IU/LPSA* 5.2ng/mL *PSA 13 months ago was 5.0 ng/mL

9. Hepatic Function? Na 141 meq/L MCHC 31.8 g/dLLDH 219 IU/L K 3.9 meq/L Plt /mm 3 Bilirubin 1.2mg/dL Cl 109 meq/LWBC 8700/mm 3 Protein 5.9mg/dL HCO 3 32 meq/L Neutros 65% Cholesterol 255mg/dL BUN 15 mg/dL Lymphs 27%Ca 8.7mg/dL Cr.8 mg/dL Monos 5%Mg 2.2mg/dL Glu 119 mg/dL Eos 2%PO 4 2.8mg/dL Hb 13.9 g/dL Basos 1%Uric acid 6.3mg/dL Hct 41%AST 31 IU/LT 4 3.5µg/dL MCV 97 fLALT 41 IU/LTSH 107.9µU/mL MCH 28.7 pg Alk phos 52 IU/LPSA* 5.2ng/mL *PSA 13 months ago was 5.0 ng/mL

10. Hb, Hct, MCV, MCH, MCHC? Na 141 meq/L MCHC 31.8 g/dLLDH 219 IU/L K 3.9 meq/L Plt /mm 3 Bilirubin 1.2mg/dL Cl 109 meq/LWBC 8700/mm 3 Protein 5.9mg/dL HCO 3 32 meq/L Neutros 65% Cholesterol 255mg/dL BUN 15 mg/dL Lymphs 27%Ca 8.7mg/dL Cr.8 mg/dL Monos 5%Mg 2.2mg/dL Glu 119 mg/dL Eos 2%PO 4 2.8mg/dL Hb 13.9 g/dL Basos 1%Uric acid 6.3mg/dL Hct 41%AST 31 IU/LT 4 3.5µg/dL MCV 97 fLALT 41 IU/LTSH 107.9µU/mL MCH 28.7 pg Alk phos 52 IU/LPSA* 5.2ng/mL *PSA 13 months ago was 5.0 ng/mL

11. T 4 and TSH? Na 141 meq/L MCHC 31.8 g/dLLDH 219 IU/L K 3.9 meq/L Plt /mm 3 Bilirubin 1.2mg/dL Cl 109 meq/LWBC 8700/mm 3 Protein 5.9mg/dL HCO 3 32 meq/L Neutros 65% Cholesterol 255mg/dL BUN 15 mg/dL Lymphs 27%Ca 8.7mg/dL Cr.8 mg/dL Monos 5%Mg 2.2mg/dL Glu 119 mg/dL Eos 2%PO 4 2.8mg/dL Hb 13.9 g/dL Basos 1%Uric acid 6.3mg/dL Hct 41%AST 31 IU/LT 4 3.5µg/dL MCV 97 fLALT 41 IU/LTSH 107.9µU/mL MCH 28.7 pg Alk phos 52 IU/LPSA* 5.2ng/mL *PSA 13 months ago was 5.0 ng/mL

12. Single most significant result? Na 141 meq/L MCHC 31.8 g/dLLDH 219 IU/L K 3.9 meq/L Plt /mm 3 Bilirubin 1.2mg/dL Cl 109 meq/LWBC 8700/mm 3 Protein 5.9mg/dL HCO 3 32 meq/L Neutros 65% Cholesterol 255mg/dL BUN 15 mg/dL Lymphs 27%Ca 8.7mg/dL Cr.8 mg/dL Monos 5%Mg 2.2mg/dL Glu 119 mg/dL Eos 2%PO 4 2.8mg/dL Hb 13.9 g/dL Basos 1%Uric acid 6.3mg/dL Hct 41%AST 31 IU/LT 4 3.5µg/dL MCV 97 fLALT 41 IU/LTSH 107.9µU/mL MCH 28.7 pg Alk phos 52 IU/LPSA* 5.2ng/mL *PSA 13 months ago was 5.0 ng/mL

Case Question 13: Provide three strong lines of evidence that this patient does not have prostate cancer

1. Low PSA 1. Physical exam findings 1. Low WBC count

Case Question 14: Pharmacotherapy or surgery?

Case Question 15 : When a patient with mild-to-moderate BPH does not respond to pharmacotherapy with 5α-reductase inhibitors or α1-blockers, what can be inferred?

the end